Our Approach

In 2009, Genentech became a member of the Roche group and the headquarters for Roche pharmaceutical operations in the United States. In 2018, Roche Partnering and Genentech Partnering merged into one global team that provides comprehensive business development and alliance management support for Roche and Genentech. Genentech maintains its own independent Research & Early Development group (gRED), allowing scientists to work freely, think and address problems in unique ways, and enhance innovation.

At Roche and Genentech, our unique company structure and culture allow us to build deep and long-lasting connections with our partners to translate pioneering science into breakthroughs for patients. We believe partnering with other companies creates a resilient and agile ecosystem, allowing innovation to thrive. We are a reliable partner, focused on growing and flourishing together, with the ultimate goal of contributing to society.

Three facts that make us a unique pharma partner:

• We are uniquely positioned to lead the next generation of healthcare - As the only company combining ground-breaking R&D, innovative pharma and diagnostic solutions with cutting-edge tech and data capabilities under one roof, we have the unique ability to support patients in their healthcare journey, from diagnosing to treating disease.
• Innovation is our lifeblood - We have a proven history of driving some of the biggest breakthroughs in science and medicine - reshaping treatment paradigms to help people with devastating and difficult-to-treat diseases. Our world-class scientific talent, spread globally across the Roche Group, is pursuing innovation in diverse ways, enabling them to tackle the big questions in healthcare from different angles. Together, we can increase our chances of success in discovering and developing further breakthroughs for patients.
• Collaboration is in our DNA - We strongly believe in the fundamental value of partnerships. Forming relationships with innovative and trustworthy companies at all stages of development is core to how we invent, discover, and develop new medicines. Working together with a strong partner like us offers smaller biotech companies additional financial stability as well as scientific and industry expertise.

Read more stories directly from our partners

Where We Are

120 of our colleagues around the globe are building the bridge between brilliant ideas coming from within Genentech and Roche and those coming from the world around us. Our global footprint with offices in South San Francisco, Basel, Boston, Cambridge, Shanghai and Tokyo offers speed, flexibility and accessibility

Our partnering process

We use an efficient four-step process to manage lasting partnerships from the first conversations to a long-term collaboration. At each step we can modify and tailor the relationship and create the structure for collaboration together, ensuring it meets both parties’ needs and creates a win-win situation for all involved. We bring in our best scientists and commercial experts early on to create deep and lasting partnerships that go beyond the initial deal. And we tap into the broad range of capabilities the Roche Group has to offer that can help patients from prevention, to diagnosis through treatment.

Partnering with Roche & Genentech is not your typical corporate experience. Our success in bringing breakthrough treatments to patients today is the result of pioneering partnerships that are built on trust, flexibility, shared values and a passion for advancing science to make a lasting contribution for people’s health. We are currently actively managing >150 partnerships globally to prove it.